Yes, but the maturation portion is discussed in the other nearby sections of the 10Q. So if it’s not BCG that portion will likely be poly-iclc, which also can boost the immune system when used as an adjuvant.
ATL/Flip- If Flippers and your assumptions are correct, Flaskworks and DCVax-L/D and XPoly ICLC and X (Keytruda or ?) will soon be going through short clinical trials?
Which no one cares about . Only way the SP will go up is with approval and some deal involving large upfront cash . Science project days are long gone .